Confounding Factors in Diagnostics of MGMT Promoter Methylation Status in Glioblastomas in Stereotactic Biopsies

Publisher： Karger

E-ISSN： 1423-0372|92|3|129-139

ISSN： 1011-6125

Source： Stereotactic and Functional Neurosurgery, Vol.92, Iss.3, 2014-04, pp. : 129-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MGMT promoter methylation is associated with temozolomide response and prolonged progression‐free survival in disseminated cutaneous melanoma

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 12, 2015-06 ,pp. : 2844-2853

John Wiley & Sons Inc

Access to resources Recommend Favorite

Screening for differential methylation status in human placenta in preeclampsia using a CpG island plus promoter microarray

By              

International Journal of Molecular Medicine, Vol. 30, Iss. 1, 2012-01 ,pp. : 133-141

Spandidos Publications

Access to resources Recommend Favorite

Methylation Status of Promoter-Associated CpG Islands in Primary Acute Myeloid Leukemia

By  

Acta Haematologica, Vol. 120, Iss. 4, 2009-01 ,pp. : 207-210

Karger

Access to resources Recommend Favorite

Current Status of Stereotactic Biopsy

By  

Stereotactic and Functional Neurosurgery, Vol. 76, Iss. 3-4, 2002-09 ,pp. : 137-139

Karger

Access to resources Recommend Favorite

Confounding

By  

Nephron Clin Pract, Vol. 116, Iss. 2, 2010-06 ,pp. : c143-c147

Karger

Access to resources Recommend Favorite